🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

India finds six cases of virus variant, may extend UK flight ban

Published 2020-12-29, 01:44 a/m
© Reuters. FILE PHOTO: India announces suspension of all flights from the UK

By Shilpa Jamkhandikar

MUMBAI (Reuters) -India has found six cases of a more infectious strain of the coronavirus, which has prompted border closures around the world, in people arriving from Britain and will likely extend a flight ban to guard against it, officials said on Tuesday.

All six of the infected people had been kept in isolation, the health ministry said in a statement, adding that their fellow travellers were being traced.

"Their close contacts have also been put under quarantine," the ministry said.

India had suspended all flights from Britain until the end of the month over worry about the infectious variant of the virus but about 33,000 passengers had flown in from late November, before the ban was enforced, the ministry said.

Of those arrivals, 114 people were found positive for the coronavirus and their samples were being checked for the new variant, which has been detected across parts of Europe and Asia, it said.

Civil Aviation Minister Hardeep Singh Puri said the ban on flights from Britain would probably remain in force into the New Year.

"I foresee a slight extension," Puri told reporters.

"I don't expect that extension to be a long or indefinite extension."

With 10.22 million confirmed infections, India has the second-highest novel coronavirus case load in the world, behind only the United States.

But on Tuesday it reported 16,432 new cases, the lowest daily rise since June 25, the health ministry said.

More than 148,150 people have died of COVID-19 in India, according to ministry data.

© Reuters. FILE PHOTO: India announces suspension of all flights from the UK

Health authorities expect to start a vaccination drive for some 300 million people early next month, with the Serum Institute of India, which is making the Oxford/AstraZeneca coronavirus shot, expecting its emergency approval within days.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.